Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.69 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.69 |
| ▸ | FAAH | O00519 | 4/20 | 0.60 |
| ▸ | DGKA | P23743 | 2/20 | 0.60 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.54 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.54 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.54 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.54 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.54 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.54 |
| ▸ | CES2 | O00748 | 1/20 | 0.54 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
| ▸ | MGLL | Q99685 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.52 |
| ▸ | RELA | Q04206 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17228588 | 1.00 | FFAR1 (0.69) | FFAR1FFAR4FAAHDGKALPAR1 | |
| SCHEMBL3659434 | 1.00 | FFAR1 (0.69) | FFAR1FFAR4FAAHDGKALPAR1 | |
| SCHEMBL1278170 | 1.00 | FFAR1 (0.69) | FFAR1FFAR4FAAHDGKALPAR1 | |
| SCHEMBL10660641 | 1.00 | FFAR1 (0.69) | FFAR1FFAR4FAAHDGKALPAR1 | |
| SCHEMBL20897199 | 1.00 | FFAR1 (0.69) | FFAR1FFAR4FAAHDGKALPAR1 | |
| SCHEMBL20897196 | 1.00 | FFAR1 (0.69) | FFAR1FFAR4FAAHDGKALPAR1 | |
| SCHEMBL25340998 | 1.00 | FFAR1 (0.69) | FFAR1FFAR4FAAHDGKALPAR1 | |
| SCHEMBL3960493 | 1.00 | FFAR1 (0.69) | FFAR1FFAR4FAAHDGKALPAR1 | |
| SCHEMBL1496224 | 1.00 | FFAR1 (0.69) | FFAR1FFAR4FAAHDGKALPAR1 | |
| SCHEMBL3657211 | 1.00 | FFAR1 (0.69) | FFAR1FFAR4FAAHDGKALPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1082365-C | Dual purpose skin moisturizing and cleansing bar composition | P & G CO (US) | 2002-04-10 | — | — | CN | claimed |
| CN-1145026-A | Combined skin moisturizing and cleaning bar composition | PROCTER & GAMBLE (US) | 1997-03-12 | — | — | CN | claimed |
| US-12582956-B2 | Articles of manufacture with polyurea capsules cross-linked with chitosan | ENCAPSYS, LLC | 2026-03-24 | — | — | US | disclosed |
| US-20250205668-A1 | Articles of Manufacture with Polyurea Capsules Cross-linked with Chitosan | ENCAPSYS, LLC (US) | 2025-06-26 | — | — | US | disclosed |
| CN-119156199-A | Antibacterial cleaning composition, use and method | 宝洁公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-119033604-A | Hair care composition comprising malodor reduction composition | 宝洁公司 | 2024-11-29 | — | — | CN | disclosed |
| EP-3934614-B1 | SKIN CARE COMPOSITIONS COMPRISING A NON-HYDROLYZED NUCLEIC ACID MATERIAL EXTRACTED FROM TUNA | KALICHEM S R L (IT) | 2024-11-27 | — | — | EP | disclosed |
| CN-119012995-A | Composition having capsules with double shell and nanoparticle layers | 宝洁公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-113543767-B | Skin care compositions comprising non-hydrolyzed nucleic acid material extracted from tuna | 嘉利化工有限责任公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-108697599-B | Hair care composition comprising malodor reduction composition | 宝洁公司 | 2024-09-17 | — | — | CN | disclosed |
| CN-118302146-A | Personal care compositions for cleansing skin | 宝洁公司 | 2024-07-05 | — | — | CN | disclosed |
| EP-1190715-A1 | Bactericide against vancomycin resistant enterococcus | Iwai, Kazuo (JP) | 2002-03-27 | — | — | EP | disclosed |
| EP-0859615-B1 | CARBOSTYRIL DERIVATIVE FOR CURING OPHTHALMOLOGICAL DISEASES | OTSUKA PHARMA CO LTD (JP) | 2001-06-13 | — | — | EP | disclosed |
| US-6060486-A | Carbostyril derivative for curing ophthalmological diseases | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2000-05-09 | — | — | US | disclosed |
| EP-0859615-A1 | CARBOSTYRIL DERIVATIVE FOR CURING OPHTHALMOLOGICAL DISEASES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1998-08-26 | — | — | EP | disclosed |
| WO-1998026769-A1 | ADP-RIBOSYLTRANSFERASE INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1998-06-25 | — | — | WO | disclosed |
| EP-0848610-A1 | USE OF A CARBOSTYRIL DERIVATIVE FOR INHIBITING CARCINOGENESIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1998-06-24 | — | — | EP | disclosed |
| WO-1997013515-A1 | CARBOSTYRIL DERIVATIVE FOR CURING OPHTHALMOLOGICAL DISEASES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-04-17 | — | — | WO | disclosed |
| WO-1997009045-A1 | USE OF A CARBOSTYRIL DERIVATIVE FOR INHIBITING CARCINOGENESIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-03-13 | — | — | WO | disclosed |
| US-4772522-A | MAGNETIC POWDER, ELECTROCONDUCTIVE MATERIAL, BINDER AND FATTY ESTER | TDK CORPORATION (JP) | 1988-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12582956-B2 | Articles of manufacture with polyurea capsules cross-linked with chitosan | SMCHD1, CEL, PUF60 | FFAR1 2298/4885FFAR4 1493/4885FAAH 846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.